Give life, give blood (@karlcarpo) 's Twitter Profile
Give life, give blood

@karlcarpo

Vexas, MDS and Sweets syndrome patient. Otherwise grand. Live life and love dogs.

ID: 183395688

calendar_today26-08-2010 22:19:06

28,28K Tweet

1,1K Takipçi

2,2K Takip Edilen

Emma M. Groarke (@emmamgroarke) 's Twitter Profile Photo

Unfortunately was not able to travel to EBMT but our poster can still be viewed virtually! We report on the first 7 #VEXAS patients who underwent allo-HCT on our prospective phase II trial. High rates of #GVHD and other inflammatory complications noted. Bhavisha Patel

Unfortunately was not able to travel to <a href="/TheEBMT/">EBMT</a> but our poster can still be viewed virtually! We report on the first 7 #VEXAS patients who underwent allo-HCT on our prospective phase II trial. High rates of #GVHD and other inflammatory complications noted. <a href="/bhavishap29/">Bhavisha Patel</a>
Emma M. Groarke (@emmamgroarke) 's Twitter Profile Photo

Congrats to FRENVEX for their study on azacitadine in #VEXAS led by Thibault Comont, MD in Blood Journal. Confirmed inflammatory & hematologic responses in >50%. Molecular responses in >2/3rds! Toxicity common especially in first 3 cycles. ashpublications.org/blood/article/… Arsene Mekinian

Congrats to FRENVEX for their study on azacitadine in #VEXAS led by <a href="/thibault_comont/">Thibault Comont, MD</a> in <a href="/BloodJournal/">Blood Journal</a>. Confirmed inflammatory &amp; hematologic responses in &gt;50%. Molecular responses in &gt;2/3rds! Toxicity common especially in first 3 cycles. ashpublications.org/blood/article/… <a href="/mekinian2/">Arsene Mekinian</a>
Jerome HADJADJ (@hadjadjjerome) 's Twitter Profile Photo

Efficacy of erythroid-stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group onlinelibrary.wiley.com/doi/10.1002/he…

Emma M. Groarke (@emmamgroarke) 's Twitter Profile Photo

Excited to see our NHLBI work on infections and immunodeficiency in patients with #telomere biology disorders now published in Blood Journals Portfolio. >1/3 had significant infection history and nearly 1/2 t-lymphopenia. Fernando Catto & Fernanda Gutierrez-Rodrigues. ashpublications.org/blood/article-…

Excited to see our NHLBI work on infections and immunodeficiency in patients with #telomere biology disorders now published in <a href="/BloodPortfolio/">Blood Journals Portfolio</a>. &gt;1/3 had significant infection history and nearly 1/2 t-lymphopenia. <a href="/FernandoCatto/">Fernando Catto</a> &amp; <a href="/fergutierrezro1/">Fernanda Gutierrez-Rodrigues</a>. ashpublications.org/blood/article-…
Hematopoiesis News (@hema_news) 's Twitter Profile Photo

Researchers led by Dr. Marcin Wlodarski (Marcin Wlodarski) reveal unique age-dependent patterns of myelodysplastic syndrome evolution and establish novel genotype-phenotype correlations with implications for clinical surveillance. 🩺 go.nature.com/3TJ4215

Researchers led by Dr. Marcin Wlodarski (<a href="/marrowgenes/">Marcin Wlodarski</a>) reveal unique age-dependent patterns of myelodysplastic syndrome evolution and establish novel genotype-phenotype correlations with implications for clinical surveillance. 🩺

go.nature.com/3TJ4215
Shernan Holtan MD (@sghmd) 's Twitter Profile Photo

💙 Hope is on the horizon. Meet Dr. Alicia Lieberman MD, MS our rheumatologist at Roswell Park, who is leading the way in using cellular therapy to fight—and one day eradicate—autoimmune diseases. For patients living with autoimmune disease, this work represents more than